These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35373885)

  • 1. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
    Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
    J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
    Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
    J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of
    Trasolini A; Erker C; Cheng S; Crowell C; McFadden K; Moineddin R; Sargent MA; Mata-Mbemba D
    AJNR Am J Neuroradiol; 2022 Aug; 43(8):1196-1201. PubMed ID: 35863783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
    Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
    AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis.
    Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C
    Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis.
    Gorodezki D; Zipfel J; Queudeville M; Sosa J; Holzer U; Kern J; Bevot A; Schittenhelm J; Nägele T; Ebinger M; Schuhmann MU
    J Neurooncol; 2022 Dec; 160(3):567-576. PubMed ID: 36319795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of
    Wagner MW; Hainc N; Khalvati F; Namdar K; Figueiredo L; Sheng M; Laughlin S; Shroff MM; Bouffet E; Tabori U; Hawkins C; Yeom KW; Ertl-Wagner BB
    AJNR Am J Neuroradiol; 2021 Apr; 42(4):759-765. PubMed ID: 33574103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
    Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
    Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric low-grade gliomas can be molecularly stratified for risk.
    Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
    Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.
    Horbinski C; Nikiforova MN; Hagenkord JM; Hamilton RL; Pollack IF
    Neuro Oncol; 2012 Jun; 14(6):777-89. PubMed ID: 22492957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
    Tateishi K; Nakamura T; Yamamoto T
    Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
    Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
    Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
    Raabe E; Kieran MW; Cohen KJ
    Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsupervised machine learning using K-means identifies radiomic subgroups of pediatric low-grade gliomas that correlate with key molecular markers.
    Haldar D; Kazerooni AF; Arif S; Familiar A; Madhogarhia R; Khalili N; Bagheri S; Anderson H; Shaikh IS; Mahtabfar A; Kim MC; Tu W; Ware J; Vossough A; Davatzikos C; Storm PB; Resnick A; Nabavizadeh A
    Neoplasia; 2023 Feb; 36():100869. PubMed ID: 36566592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.
    Kai Z; Dingyang L; Zhuanyi Y
    World Neurosurg; 2021 Mar; 147():42-46. PubMed ID: 33316486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
    Nobre L; Zapotocky M; Ramaswamy V; Ryall S; Bennett J; Alderete D; Balaguer Guill J; Baroni L; Bartels U; Bavle A; Bornhorst M; Boue DR; Canete A; Chintagumpala M; Coven SL; Cruz O; Dahiya S; Dirks P; Dunkel IJ; Eisenstat D; Faure Conter C; Finch E; Finlay JL; Frappaz D; Garre ML; Gauvain K; Bechensteen AG; Hansford JR; Harting I; Hauser P; Hazrati LN; Huang A; Injac SG; Iurilli V; Karajannis M; Kaur G; Kyncl M; Krskova L; Laperriere N; Larouche V; Lassaletta A; Leary S; Lin F; Mascelli S; McKeown T; Milde T; Morales La Madrid A; Morana G; Morse H; Mushtaq N; Osorio DS; Packer R; Pavelka Z; Quiroga-Cantero E; Rutka J; Sabel M; Salgado D; Solano P; Sterba J; Su J; Sumerauer D; Taylor MD; Toledano H; Tsang DS; Valente Fernandes M; van Landeghem F; van Tilburg CM; Wilson B; Witt O; Zamecnik J; Bouffet E; Hawkins C; Tabori U
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
    Fukuoka K; Mamatjan Y; Tatevossian R; Zapotocky M; Ryall S; Stucklin AG; Bennett J; Nobre LF; Arnoldo A; Luu B; Wen J; Zhu K; Leon A; Torti D; Pugh TJ; Hazrati LN; Laperriere N; Drake J; Rutka JT; Dirks P; Kulkarni AV; Taylor MD; Bartels U; Huang A; Zadeh G; Aldape K; Ramaswamy V; Bouffet E; Snuderl M; Ellison D; Hawkins C; Tabori U
    Neuro Oncol; 2020 Oct; 22(10):1474-1483. PubMed ID: 32242226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation.
    Dodgshun AJ; SantaCruz N; Hwang J; Ramkissoon SH; Malkin H; Bergthold G; Manley P; Chi S; MacGregor D; Goumnerova L; Sullivan M; Ligon K; Beroukhim R; Herrington B; Kieran MW; Hansford JR; Bandopadhayay P
    J Neurooncol; 2016 Jun; 128(2):293-302. PubMed ID: 26994902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.